SlideShare ist ein Scribd-Unternehmen logo
1 von 10
Peer Reviewed Penn State and BYU Study This study reveals: ,[object Object]
The misconception that HPV is only an STD, when in truth it has also been spread for decades through medical instruments
  Answers as to the extremely high numbers of infected young and old men and women worldwide
  Severe cause for an international EMERGENCY MEDICAL ALERT,[object Object]
Susceptibility of Native and Synthetic HPV 16 Virions to Clinical DisinfectantsJ.M. Meyers, E. Ryndock, M.J. Conway, K.L. O’Neill, C.M. Meyers, R.A. RobisonBrigham Young Univ. Provo, UT - Pennsylvania State College of Medicine Hershey, PA Abstract Method Human papillomavirus (HPV) represents one of the most prevalent sexually transmitted infections in the United States.  Even after the advent of two FDA approved commercial vaccines, HPV constitutes a significant burden of cancer occurrence and death.  Among sexually transmitted HPV types, those that frequently cause viral-induced cancers are classified as high-risk.  The susceptibility of HPV to disinfection has not been described due to the lack of a suitable infectivity assay and the inability to produce sufficient HPV particles.   Introduction Source:  Penn State Univ. BYU Susceptibility of Native and Synthetic HPV16 Virions to Clinical Disinfectants ASM Poster.
Susceptibility of Native and Synthetic HPV 16 Virions to Clinical DisinfectantsJ.M. Meyers, E. Ryndock, M.J. Conway, K.L. O’Neill, C.M. Meyers, R.A. RobisonBrigham Young Univ. Provo, UT - Pennsylvania State College of Medicine Hershey, PA Abstract Method   All disinfectants were tested at recommended concentrations and at a 45 minute contact time. The results of these studies show that some disinfectants routinely used on medical instruments and devices may not be effective at inactivating HPV, leaving open the possibility of a nonsexual transmission route for HPV infection.  Also, these data suggest that quasivirions may not have the same disinfectant resistance as more naturally-derived virions, suggesting that their use as surrogates may be problematic. Introduction Source:  Penn State Univ. BYU Susceptibility of Native and Synthetic HPV16 Virions to Clinical Disinfectants ASM Poster.
Susceptibility of Native and Synthetic HPV 16 Virions to Clinical DisinfectantsJ.M. Meyers, E. Ryndock, M.J. Conway, K.L. O’Neill, C.M. Meyers, R.A. RobisonBrigham Young Univ. Provo, UT - Pennsylvania State College of Medicine Hershey, PA Abstract Method   Epidemiological evidence suggests that infection routes exist outside of sexual transmission.  Some of the non-sexual transmission of HPV can be ascribed to vertical transmission from infected mother to child, yet there remains a population who are positive for infection and have none of the classical risk factors.  The purpose of this study was to establish an assay system for determining susceptibility of high-risk HPV16 using both virus propagation methods, and to determine the effect of various chemical disinfectants on these virions to establish the first disinfectant susceptibility data for HPV. Introduction Source:  Penn State Univ. BYU Susceptibility of Native and Synthetic HPV16 Virions to Clinical Disinfectants ASM Poster.
Susceptibility of Native and Synthetic HPV 16 Virions to Clinical DisinfectantsJ.M. Meyers, E. Ryndock, M.J. Conway, K.L. O’Neill, C.M. Meyers, R.A. RobisonBrigham Young Univ. Provo, UT - Pennsylvania State College of Medicine Hershey, PA Results Conclusions These results show the first disinfectant susceptibility data against infectious human papillomavirus particles.  Specifically, we have shown the most common high-risk HPV type, HPV 16, to be resistant to many commonly used disinfectants.  Both of the oxidative disinfectants we tested were shown to be effective, suggesting that this property might be important for activity against this virus. In general, ethanol has been shown to be more effective against envelope as compared to non-envelope viruses. However, ethanol has shown to be effective against polioviruses and adenoviruses.  These data show ethanol to have no effective against HPV.  To date, no viruses have shown significant resistance to glutaraldehyde.  These data suggest that HPV 16 is resistant to both glutaraldehyde and ortho-phthalaldehyde.  This is significant in that these are common high-level disinfectants used in clinics are when heat sterilization is not possible or available. Many of the ineffective disinfectants showed a consistent low increase in infectivity after treatment.   Our data also supports a large amount of epidemiological and clinical data that suggest long-term environmental stability of HPV. While the vast majority of high-risk HPV infections can be attributed to sexual activity, this data helps explain non-vertical and non-sexual acquisition of HPV as well as a persistence of infection.  Of the disinfectants tested, the only disinfectants able to achieve greater than a three log10 reduction of HPV infectivity were sodium hypochlorite (0.525% bleach solution by MarketLab) and a silver/PAA-based disinfectant (Steriplex by sBioMed). Preliminary data for the quasivirus with select disinfectants is also shown. All data were obtained using a 45 minute contact time. Table 1. Results of Disinfectant Testing LOG REDUCTION Native Virions 5.90 LOG REDUCTION Quasivirions 5.80 PEROXYACETIC ACID (1.3%) SILVER (0.03%) STERIPLEX ULTRA Source:  Penn State Univ. BYU Susceptibility of Native and Synthetic HPV16 Virions to Clinical Disinfectants ASM Poster.
Susceptibility of Native and Synthetic HPV 16 Virions to Clinical DisinfectantsJ.M. Meyers, E. Ryndock, M.J. Conway, K.L. O’Neill, C.M. Meyers, R.A. RobisonBrigham Young Univ. Provo, UT - Pennsylvania State College of Medicine Hershey, PA Results Conclusions These results show the first disinfectant susceptibility data against infectious human papillomavirus particles.  Specifically, we have shown the most common high-risk HPV type, HPV 16, to be resistant to many commonly used disinfectants.  Both of the oxidative disinfectants we tested were shown to be effective, suggesting that this property might be important for activity against this virus. In general, ethanol has been shown to be more effective against envelope as compared to non-envelope viruses. However, ethanol has shown to be effective against polioviruses and adenoviruses.  These data show ethanol to have no effective against HPV.  To date, no viruses have shown significant resistance to glutaraldehyde.  These data suggest that HPV 16 is resistant to both glutaraldehyde and ortho-phthalaldehyde.  This is significant in that these are common high-level disinfectants used in clinics are when heat sterilization is not possible or available. Many of the ineffective disinfectants showed a consistent low increase in infectivity after treatment.   Our data also supports a large amount of epidemiological and clinical data that suggest long-term environmental stability of HPV. While the vast majority of high-risk HPV infections can be attributed to sexual activity, this data helps explain non-vertical and non-sexual acquisition of HPV as well as a persistence of infection.  Of the disinfectants tested, the only disinfectants able to achieve greater than a three log10 reduction of HPV infectivity were sodium hypochlorite (0.525% bleach solution by MarketLab) and a silver/PAA-based disinfectant (Steriplex by sBioMed). Preliminary data for the quasivirus with select disinfectants is also shown. All data were obtained using a 45 minute contact time. Table 1. Results of Disinfectant Testing To date, no viruses have shown significant resistance to     glutaraldehyde. These data suggest that HPV 16 is resistant to both glutaraldehyde and ortho-phthalaldehyde. This is significant in that these are common high-level disinfectants used in clinics when heat sterilization is not possible or available. While the vast majority of high-risk HPV infections can be attributed to sexual activity,this data helps explain non-vertical and non-sexual acquisition of HPV as well as a persistence of infection. Source:  Penn State Univ. BYU Susceptibility of Native and Synthetic HPV16 Virions to Clinical Disinfectants ASM Poster.

Weitere ähnliche Inhalte

Was ist angesagt?

Natural history and pathogenesis of hpv
Natural history and pathogenesis of hpvNatural history and pathogenesis of hpv
Natural history and pathogenesis of hpvTariq Mohammed
 
Qick review for resedent nisrin
Qick review for resedent nisrinQick review for resedent nisrin
Qick review for resedent nisrinTariq Mohammed
 
Hpv - Human Papilloma Virus
Hpv - Human Papilloma VirusHpv - Human Papilloma Virus
Hpv - Human Papilloma VirusZanoula
 
Human Papilloma Virus
Human Papilloma VirusHuman Papilloma Virus
Human Papilloma Virusdrsubir
 
Vaccination Against Cervical Cancer
Vaccination Against Cervical CancerVaccination Against Cervical Cancer
Vaccination Against Cervical CancerRaymond Arhin
 
Human papilloma virus in oropharyngeal cancers
Human papilloma virus in oropharyngeal cancersHuman papilloma virus in oropharyngeal cancers
Human papilloma virus in oropharyngeal cancersAhmad Qudah
 
Human Papilloma Virus (HPV) - Kelsi Butler
Human Papilloma Virus (HPV) - Kelsi ButlerHuman Papilloma Virus (HPV) - Kelsi Butler
Human Papilloma Virus (HPV) - Kelsi Butlerkelsibutler
 
Wondering facts hpv vaccines are reducing infections, warts and probably cancer.
Wondering facts hpv vaccines are reducing infections, warts and probably cancer.Wondering facts hpv vaccines are reducing infections, warts and probably cancer.
Wondering facts hpv vaccines are reducing infections, warts and probably cancer.Root India Healthcare
 
Monitoring efficacy gene expression frontiers
Monitoring efficacy gene expression frontiersMonitoring efficacy gene expression frontiers
Monitoring efficacy gene expression frontiersEliyahu Schuman
 
Human papilloma virus vaccine - Egypt
Human papilloma virus vaccine - EgyptHuman papilloma virus vaccine - Egypt
Human papilloma virus vaccine - EgyptMoustapha Ramadan
 
Cancer Biomarkers Research, HPV and Cancer, HPV Vaccine
Cancer Biomarkers Research, HPV and Cancer, HPV VaccineCancer Biomarkers Research, HPV and Cancer, HPV Vaccine
Cancer Biomarkers Research, HPV and Cancer, HPV VaccineJames Lyons-Weiler
 
Associations of MHC Ancestral Haplotypes with Resistance/Susceptibility to AI...
Associations of MHC Ancestral Haplotypes with Resistance/Susceptibility to AI...Associations of MHC Ancestral Haplotypes with Resistance/Susceptibility to AI...
Associations of MHC Ancestral Haplotypes with Resistance/Susceptibility to AI...Dr. Juan Rodriguez-Tafur
 
Oncolytic Virus Therapy Development - Creative Biolabs
Oncolytic Virus Therapy Development - Creative BiolabsOncolytic Virus Therapy Development - Creative Biolabs
Oncolytic Virus Therapy Development - Creative BiolabsCreative-Biolabs
 
Hiv aids sample questions based on neet pg , usmle, plab and fmge pattern (mc...
Hiv aids sample questions based on neet pg , usmle, plab and fmge pattern (mc...Hiv aids sample questions based on neet pg , usmle, plab and fmge pattern (mc...
Hiv aids sample questions based on neet pg , usmle, plab and fmge pattern (mc...Medico Apps
 
Information for the Patient on Human Papilloma Virus (HPV) and Head and Neck ...
Information for the Patient on Human Papilloma Virus (HPV) and Head and Neck ...Information for the Patient on Human Papilloma Virus (HPV) and Head and Neck ...
Information for the Patient on Human Papilloma Virus (HPV) and Head and Neck ...American Head and Neck Society
 

Was ist angesagt? (18)

Natural history and pathogenesis of hpv
Natural history and pathogenesis of hpvNatural history and pathogenesis of hpv
Natural history and pathogenesis of hpv
 
Qick review for resedent nisrin
Qick review for resedent nisrinQick review for resedent nisrin
Qick review for resedent nisrin
 
Hpv - Human Papilloma Virus
Hpv - Human Papilloma VirusHpv - Human Papilloma Virus
Hpv - Human Papilloma Virus
 
Human Papilloma Virus
Human Papilloma VirusHuman Papilloma Virus
Human Papilloma Virus
 
Vaccination Against Cervical Cancer
Vaccination Against Cervical CancerVaccination Against Cervical Cancer
Vaccination Against Cervical Cancer
 
Human papilloma virus in oropharyngeal cancers
Human papilloma virus in oropharyngeal cancersHuman papilloma virus in oropharyngeal cancers
Human papilloma virus in oropharyngeal cancers
 
Human Papilloma Virus (HPV) - Kelsi Butler
Human Papilloma Virus (HPV) - Kelsi ButlerHuman Papilloma Virus (HPV) - Kelsi Butler
Human Papilloma Virus (HPV) - Kelsi Butler
 
Wondering facts hpv vaccines are reducing infections, warts and probably cancer.
Wondering facts hpv vaccines are reducing infections, warts and probably cancer.Wondering facts hpv vaccines are reducing infections, warts and probably cancer.
Wondering facts hpv vaccines are reducing infections, warts and probably cancer.
 
Monitoring efficacy gene expression frontiers
Monitoring efficacy gene expression frontiersMonitoring efficacy gene expression frontiers
Monitoring efficacy gene expression frontiers
 
2011 populations genetics gypb
2011 populations genetics gypb2011 populations genetics gypb
2011 populations genetics gypb
 
Human papilloma virus vaccine - Egypt
Human papilloma virus vaccine - EgyptHuman papilloma virus vaccine - Egypt
Human papilloma virus vaccine - Egypt
 
7. hcv in mexico
7. hcv in mexico7. hcv in mexico
7. hcv in mexico
 
Cancer Biomarkers Research, HPV and Cancer, HPV Vaccine
Cancer Biomarkers Research, HPV and Cancer, HPV VaccineCancer Biomarkers Research, HPV and Cancer, HPV Vaccine
Cancer Biomarkers Research, HPV and Cancer, HPV Vaccine
 
Associations of MHC Ancestral Haplotypes with Resistance/Susceptibility to AI...
Associations of MHC Ancestral Haplotypes with Resistance/Susceptibility to AI...Associations of MHC Ancestral Haplotypes with Resistance/Susceptibility to AI...
Associations of MHC Ancestral Haplotypes with Resistance/Susceptibility to AI...
 
Oncolytic Virus Therapy Development - Creative Biolabs
Oncolytic Virus Therapy Development - Creative BiolabsOncolytic Virus Therapy Development - Creative Biolabs
Oncolytic Virus Therapy Development - Creative Biolabs
 
Nature.2015.18787 covid
Nature.2015.18787 covidNature.2015.18787 covid
Nature.2015.18787 covid
 
Hiv aids sample questions based on neet pg , usmle, plab and fmge pattern (mc...
Hiv aids sample questions based on neet pg , usmle, plab and fmge pattern (mc...Hiv aids sample questions based on neet pg , usmle, plab and fmge pattern (mc...
Hiv aids sample questions based on neet pg , usmle, plab and fmge pattern (mc...
 
Information for the Patient on Human Papilloma Virus (HPV) and Head and Neck ...
Information for the Patient on Human Papilloma Virus (HPV) and Head and Neck ...Information for the Patient on Human Papilloma Virus (HPV) and Head and Neck ...
Information for the Patient on Human Papilloma Virus (HPV) and Head and Neck ...
 

Ähnlich wie Looping hpv power point

Hpv y ca cervical causalidad
Hpv y ca cervical causalidadHpv y ca cervical causalidad
Hpv y ca cervical causalidadRaul Campusano
 
All about the Human Papillomavirus
All about the Human PapillomavirusAll about the Human Papillomavirus
All about the Human PapillomavirusJESSICALAGAMERRR
 
Cervical Dysplasia and High-Risk Human Papillomavirus Infections among HIV-In...
Cervical Dysplasia and High-Risk Human Papillomavirus Infections among HIV-In...Cervical Dysplasia and High-Risk Human Papillomavirus Infections among HIV-In...
Cervical Dysplasia and High-Risk Human Papillomavirus Infections among HIV-In...capegynecologist
 
Topic Human Papillomavirus and the Fight to Protect and Health.docx
Topic Human Papillomavirus and the Fight to Protect and Health.docxTopic Human Papillomavirus and the Fight to Protect and Health.docx
Topic Human Papillomavirus and the Fight to Protect and Health.docxwrite5
 
What is Human Papillomavirus (HPV)? Infections and Prevention | The Lifescien...
What is Human Papillomavirus (HPV)? Infections and Prevention | The Lifescien...What is Human Papillomavirus (HPV)? Infections and Prevention | The Lifescien...
What is Human Papillomavirus (HPV)? Infections and Prevention | The Lifescien...The Lifesciences Magazine
 
Human papillomavirus (HPV) Vaccine
Human papillomavirus (HPV) VaccineHuman papillomavirus (HPV) Vaccine
Human papillomavirus (HPV) VaccineKeith Wassung
 
The causal relation between human papillomavirus and cervical cancer
The causal relation between human papillomavirus and cervical cancerThe causal relation between human papillomavirus and cervical cancer
The causal relation between human papillomavirus and cervical cancerAlberto Cuadrado
 
Natural history of human papillomavirus infections, cytologic and histologic ...
Natural history of human papillomavirus infections, cytologic and histologic ...Natural history of human papillomavirus infections, cytologic and histologic ...
Natural history of human papillomavirus infections, cytologic and histologic ...Eliana Cordero
 
Michael Marco ID Epi class slides on HPV Natural History
Michael Marco ID Epi class slides on HPV Natural HistoryMichael Marco ID Epi class slides on HPV Natural History
Michael Marco ID Epi class slides on HPV Natural Historymikemarco
 
Dr. nisreen cervical cancer screening in park hayat
Dr. nisreen cervical cancer screening in park hayatDr. nisreen cervical cancer screening in park hayat
Dr. nisreen cervical cancer screening in park hayatTariq Mohammed
 
REVISTA VACUNACION VPH Semana 10.pdf
REVISTA VACUNACION VPH Semana 10.pdfREVISTA VACUNACION VPH Semana 10.pdf
REVISTA VACUNACION VPH Semana 10.pdfManuelDiazEstrada2
 
Viruses and Cancer: Introduction to Oncoviruses
Viruses and Cancer: Introduction to OncovirusesViruses and Cancer: Introduction to Oncoviruses
Viruses and Cancer: Introduction to OncovirusesAparna Dubey
 

Ähnlich wie Looping hpv power point (20)

Hpv Cause For Disease
Hpv Cause For DiseaseHpv Cause For Disease
Hpv Cause For Disease
 
5.17.11.hpv in males
5.17.11.hpv in males5.17.11.hpv in males
5.17.11.hpv in males
 
Hpv y ca cervical causalidad
Hpv y ca cervical causalidadHpv y ca cervical causalidad
Hpv y ca cervical causalidad
 
Vph
VphVph
Vph
 
All about the Human Papillomavirus
All about the Human PapillomavirusAll about the Human Papillomavirus
All about the Human Papillomavirus
 
Cervical Dysplasia and High-Risk Human Papillomavirus Infections among HIV-In...
Cervical Dysplasia and High-Risk Human Papillomavirus Infections among HIV-In...Cervical Dysplasia and High-Risk Human Papillomavirus Infections among HIV-In...
Cervical Dysplasia and High-Risk Human Papillomavirus Infections among HIV-In...
 
Topic Human Papillomavirus and the Fight to Protect and Health.docx
Topic Human Papillomavirus and the Fight to Protect and Health.docxTopic Human Papillomavirus and the Fight to Protect and Health.docx
Topic Human Papillomavirus and the Fight to Protect and Health.docx
 
What is Human Papillomavirus (HPV)? Infections and Prevention | The Lifescien...
What is Human Papillomavirus (HPV)? Infections and Prevention | The Lifescien...What is Human Papillomavirus (HPV)? Infections and Prevention | The Lifescien...
What is Human Papillomavirus (HPV)? Infections and Prevention | The Lifescien...
 
Human papillomavirus (HPV) Vaccine
Human papillomavirus (HPV) VaccineHuman papillomavirus (HPV) Vaccine
Human papillomavirus (HPV) Vaccine
 
The causal relation between human papillomavirus and cervical cancer
The causal relation between human papillomavirus and cervical cancerThe causal relation between human papillomavirus and cervical cancer
The causal relation between human papillomavirus and cervical cancer
 
Oncogenic virus ppt
Oncogenic virus pptOncogenic virus ppt
Oncogenic virus ppt
 
Manejo del condiloma acuminado anal
Manejo del condiloma acuminado analManejo del condiloma acuminado anal
Manejo del condiloma acuminado anal
 
Natural history of human papillomavirus infections, cytologic and histologic ...
Natural history of human papillomavirus infections, cytologic and histologic ...Natural history of human papillomavirus infections, cytologic and histologic ...
Natural history of human papillomavirus infections, cytologic and histologic ...
 
Michael Marco ID Epi class slides on HPV Natural History
Michael Marco ID Epi class slides on HPV Natural HistoryMichael Marco ID Epi class slides on HPV Natural History
Michael Marco ID Epi class slides on HPV Natural History
 
HPV Vaccine Recommendations (AAP)
HPV Vaccine Recommendations (AAP)HPV Vaccine Recommendations (AAP)
HPV Vaccine Recommendations (AAP)
 
Dr. nisreen cervical cancer screening in park hayat
Dr. nisreen cervical cancer screening in park hayatDr. nisreen cervical cancer screening in park hayat
Dr. nisreen cervical cancer screening in park hayat
 
Human papilloma virus
Human papilloma virusHuman papilloma virus
Human papilloma virus
 
Vacunacion pvh
Vacunacion pvhVacunacion pvh
Vacunacion pvh
 
REVISTA VACUNACION VPH Semana 10.pdf
REVISTA VACUNACION VPH Semana 10.pdfREVISTA VACUNACION VPH Semana 10.pdf
REVISTA VACUNACION VPH Semana 10.pdf
 
Viruses and Cancer: Introduction to Oncoviruses
Viruses and Cancer: Introduction to OncovirusesViruses and Cancer: Introduction to Oncoviruses
Viruses and Cancer: Introduction to Oncoviruses
 

Kürzlich hochgeladen

The CMO Survey - Highlights and Insights Report - Spring 2024
The CMO Survey - Highlights and Insights Report - Spring 2024The CMO Survey - Highlights and Insights Report - Spring 2024
The CMO Survey - Highlights and Insights Report - Spring 2024christinemoorman
 
Market Sizes Sample Report - 2024 Edition
Market Sizes Sample Report - 2024 EditionMarket Sizes Sample Report - 2024 Edition
Market Sizes Sample Report - 2024 EditionMintel Group
 
Independent Call Girls Andheri Nightlaila 9967584737
Independent Call Girls Andheri Nightlaila 9967584737Independent Call Girls Andheri Nightlaila 9967584737
Independent Call Girls Andheri Nightlaila 9967584737Riya Pathan
 
Pitch Deck Teardown: Geodesic.Life's $500k Pre-seed deck
Pitch Deck Teardown: Geodesic.Life's $500k Pre-seed deckPitch Deck Teardown: Geodesic.Life's $500k Pre-seed deck
Pitch Deck Teardown: Geodesic.Life's $500k Pre-seed deckHajeJanKamps
 
Call Girls Miyapur 7001305949 all area service COD available Any Time
Call Girls Miyapur 7001305949 all area service COD available Any TimeCall Girls Miyapur 7001305949 all area service COD available Any Time
Call Girls Miyapur 7001305949 all area service COD available Any Timedelhimodelshub1
 
Buy gmail accounts.pdf Buy Old Gmail Accounts
Buy gmail accounts.pdf Buy Old Gmail AccountsBuy gmail accounts.pdf Buy Old Gmail Accounts
Buy gmail accounts.pdf Buy Old Gmail AccountsBuy Verified Accounts
 
BEST Call Girls In Greater Noida ✨ 9773824855 ✨ Escorts Service In Delhi Ncr,
BEST Call Girls In Greater Noida ✨ 9773824855 ✨ Escorts Service In Delhi Ncr,BEST Call Girls In Greater Noida ✨ 9773824855 ✨ Escorts Service In Delhi Ncr,
BEST Call Girls In Greater Noida ✨ 9773824855 ✨ Escorts Service In Delhi Ncr,noida100girls
 
Call Girls In Radisson Blu Hotel New Delhi Paschim Vihar ❤️8860477959 Escorts...
Call Girls In Radisson Blu Hotel New Delhi Paschim Vihar ❤️8860477959 Escorts...Call Girls In Radisson Blu Hotel New Delhi Paschim Vihar ❤️8860477959 Escorts...
Call Girls In Radisson Blu Hotel New Delhi Paschim Vihar ❤️8860477959 Escorts...lizamodels9
 
FULL ENJOY Call girls in Paharganj Delhi | 8377087607
FULL ENJOY Call girls in Paharganj Delhi | 8377087607FULL ENJOY Call girls in Paharganj Delhi | 8377087607
FULL ENJOY Call girls in Paharganj Delhi | 8377087607dollysharma2066
 
Flow Your Strategy at Flight Levels Day 2024
Flow Your Strategy at Flight Levels Day 2024Flow Your Strategy at Flight Levels Day 2024
Flow Your Strategy at Flight Levels Day 2024Kirill Klimov
 
8447779800, Low rate Call girls in Saket Delhi NCR
8447779800, Low rate Call girls in Saket Delhi NCR8447779800, Low rate Call girls in Saket Delhi NCR
8447779800, Low rate Call girls in Saket Delhi NCRashishs7044
 
8447779800, Low rate Call girls in Shivaji Enclave Delhi NCR
8447779800, Low rate Call girls in Shivaji Enclave Delhi NCR8447779800, Low rate Call girls in Shivaji Enclave Delhi NCR
8447779800, Low rate Call girls in Shivaji Enclave Delhi NCRashishs7044
 
Kenya Coconut Production Presentation by Dr. Lalith Perera
Kenya Coconut Production Presentation by Dr. Lalith PereraKenya Coconut Production Presentation by Dr. Lalith Perera
Kenya Coconut Production Presentation by Dr. Lalith Pereraictsugar
 
Contemporary Economic Issues Facing the Filipino Entrepreneur (1).pptx
Contemporary Economic Issues Facing the Filipino Entrepreneur (1).pptxContemporary Economic Issues Facing the Filipino Entrepreneur (1).pptx
Contemporary Economic Issues Facing the Filipino Entrepreneur (1).pptxMarkAnthonyAurellano
 
Lowrate Call Girls In Sector 18 Noida ❤️8860477959 Escorts 100% Genuine Servi...
Lowrate Call Girls In Sector 18 Noida ❤️8860477959 Escorts 100% Genuine Servi...Lowrate Call Girls In Sector 18 Noida ❤️8860477959 Escorts 100% Genuine Servi...
Lowrate Call Girls In Sector 18 Noida ❤️8860477959 Escorts 100% Genuine Servi...lizamodels9
 
BEST Call Girls In Old Faridabad ✨ 9773824855 ✨ Escorts Service In Delhi Ncr,
BEST Call Girls In Old Faridabad ✨ 9773824855 ✨ Escorts Service In Delhi Ncr,BEST Call Girls In Old Faridabad ✨ 9773824855 ✨ Escorts Service In Delhi Ncr,
BEST Call Girls In Old Faridabad ✨ 9773824855 ✨ Escorts Service In Delhi Ncr,noida100girls
 
Ten Organizational Design Models to align structure and operations to busines...
Ten Organizational Design Models to align structure and operations to busines...Ten Organizational Design Models to align structure and operations to busines...
Ten Organizational Design Models to align structure and operations to busines...Seta Wicaksana
 
Intro to BCG's Carbon Emissions Benchmark_vF.pdf
Intro to BCG's Carbon Emissions Benchmark_vF.pdfIntro to BCG's Carbon Emissions Benchmark_vF.pdf
Intro to BCG's Carbon Emissions Benchmark_vF.pdfpollardmorgan
 
NewBase 19 April 2024 Energy News issue - 1717 by Khaled Al Awadi.pdf
NewBase  19 April  2024  Energy News issue - 1717 by Khaled Al Awadi.pdfNewBase  19 April  2024  Energy News issue - 1717 by Khaled Al Awadi.pdf
NewBase 19 April 2024 Energy News issue - 1717 by Khaled Al Awadi.pdfKhaled Al Awadi
 

Kürzlich hochgeladen (20)

The CMO Survey - Highlights and Insights Report - Spring 2024
The CMO Survey - Highlights and Insights Report - Spring 2024The CMO Survey - Highlights and Insights Report - Spring 2024
The CMO Survey - Highlights and Insights Report - Spring 2024
 
Market Sizes Sample Report - 2024 Edition
Market Sizes Sample Report - 2024 EditionMarket Sizes Sample Report - 2024 Edition
Market Sizes Sample Report - 2024 Edition
 
Independent Call Girls Andheri Nightlaila 9967584737
Independent Call Girls Andheri Nightlaila 9967584737Independent Call Girls Andheri Nightlaila 9967584737
Independent Call Girls Andheri Nightlaila 9967584737
 
Corporate Profile 47Billion Information Technology
Corporate Profile 47Billion Information TechnologyCorporate Profile 47Billion Information Technology
Corporate Profile 47Billion Information Technology
 
Pitch Deck Teardown: Geodesic.Life's $500k Pre-seed deck
Pitch Deck Teardown: Geodesic.Life's $500k Pre-seed deckPitch Deck Teardown: Geodesic.Life's $500k Pre-seed deck
Pitch Deck Teardown: Geodesic.Life's $500k Pre-seed deck
 
Call Girls Miyapur 7001305949 all area service COD available Any Time
Call Girls Miyapur 7001305949 all area service COD available Any TimeCall Girls Miyapur 7001305949 all area service COD available Any Time
Call Girls Miyapur 7001305949 all area service COD available Any Time
 
Buy gmail accounts.pdf Buy Old Gmail Accounts
Buy gmail accounts.pdf Buy Old Gmail AccountsBuy gmail accounts.pdf Buy Old Gmail Accounts
Buy gmail accounts.pdf Buy Old Gmail Accounts
 
BEST Call Girls In Greater Noida ✨ 9773824855 ✨ Escorts Service In Delhi Ncr,
BEST Call Girls In Greater Noida ✨ 9773824855 ✨ Escorts Service In Delhi Ncr,BEST Call Girls In Greater Noida ✨ 9773824855 ✨ Escorts Service In Delhi Ncr,
BEST Call Girls In Greater Noida ✨ 9773824855 ✨ Escorts Service In Delhi Ncr,
 
Call Girls In Radisson Blu Hotel New Delhi Paschim Vihar ❤️8860477959 Escorts...
Call Girls In Radisson Blu Hotel New Delhi Paschim Vihar ❤️8860477959 Escorts...Call Girls In Radisson Blu Hotel New Delhi Paschim Vihar ❤️8860477959 Escorts...
Call Girls In Radisson Blu Hotel New Delhi Paschim Vihar ❤️8860477959 Escorts...
 
FULL ENJOY Call girls in Paharganj Delhi | 8377087607
FULL ENJOY Call girls in Paharganj Delhi | 8377087607FULL ENJOY Call girls in Paharganj Delhi | 8377087607
FULL ENJOY Call girls in Paharganj Delhi | 8377087607
 
Flow Your Strategy at Flight Levels Day 2024
Flow Your Strategy at Flight Levels Day 2024Flow Your Strategy at Flight Levels Day 2024
Flow Your Strategy at Flight Levels Day 2024
 
8447779800, Low rate Call girls in Saket Delhi NCR
8447779800, Low rate Call girls in Saket Delhi NCR8447779800, Low rate Call girls in Saket Delhi NCR
8447779800, Low rate Call girls in Saket Delhi NCR
 
8447779800, Low rate Call girls in Shivaji Enclave Delhi NCR
8447779800, Low rate Call girls in Shivaji Enclave Delhi NCR8447779800, Low rate Call girls in Shivaji Enclave Delhi NCR
8447779800, Low rate Call girls in Shivaji Enclave Delhi NCR
 
Kenya Coconut Production Presentation by Dr. Lalith Perera
Kenya Coconut Production Presentation by Dr. Lalith PereraKenya Coconut Production Presentation by Dr. Lalith Perera
Kenya Coconut Production Presentation by Dr. Lalith Perera
 
Contemporary Economic Issues Facing the Filipino Entrepreneur (1).pptx
Contemporary Economic Issues Facing the Filipino Entrepreneur (1).pptxContemporary Economic Issues Facing the Filipino Entrepreneur (1).pptx
Contemporary Economic Issues Facing the Filipino Entrepreneur (1).pptx
 
Lowrate Call Girls In Sector 18 Noida ❤️8860477959 Escorts 100% Genuine Servi...
Lowrate Call Girls In Sector 18 Noida ❤️8860477959 Escorts 100% Genuine Servi...Lowrate Call Girls In Sector 18 Noida ❤️8860477959 Escorts 100% Genuine Servi...
Lowrate Call Girls In Sector 18 Noida ❤️8860477959 Escorts 100% Genuine Servi...
 
BEST Call Girls In Old Faridabad ✨ 9773824855 ✨ Escorts Service In Delhi Ncr,
BEST Call Girls In Old Faridabad ✨ 9773824855 ✨ Escorts Service In Delhi Ncr,BEST Call Girls In Old Faridabad ✨ 9773824855 ✨ Escorts Service In Delhi Ncr,
BEST Call Girls In Old Faridabad ✨ 9773824855 ✨ Escorts Service In Delhi Ncr,
 
Ten Organizational Design Models to align structure and operations to busines...
Ten Organizational Design Models to align structure and operations to busines...Ten Organizational Design Models to align structure and operations to busines...
Ten Organizational Design Models to align structure and operations to busines...
 
Intro to BCG's Carbon Emissions Benchmark_vF.pdf
Intro to BCG's Carbon Emissions Benchmark_vF.pdfIntro to BCG's Carbon Emissions Benchmark_vF.pdf
Intro to BCG's Carbon Emissions Benchmark_vF.pdf
 
NewBase 19 April 2024 Energy News issue - 1717 by Khaled Al Awadi.pdf
NewBase  19 April  2024  Energy News issue - 1717 by Khaled Al Awadi.pdfNewBase  19 April  2024  Energy News issue - 1717 by Khaled Al Awadi.pdf
NewBase 19 April 2024 Energy News issue - 1717 by Khaled Al Awadi.pdf
 

Looping hpv power point

  • 1.
  • 2.
  • 3. The misconception that HPV is only an STD, when in truth it has also been spread for decades through medical instruments
  • 4. Answers as to the extremely high numbers of infected young and old men and women worldwide
  • 5.
  • 6. Susceptibility of Native and Synthetic HPV 16 Virions to Clinical DisinfectantsJ.M. Meyers, E. Ryndock, M.J. Conway, K.L. O’Neill, C.M. Meyers, R.A. RobisonBrigham Young Univ. Provo, UT - Pennsylvania State College of Medicine Hershey, PA Abstract Method Human papillomavirus (HPV) represents one of the most prevalent sexually transmitted infections in the United States. Even after the advent of two FDA approved commercial vaccines, HPV constitutes a significant burden of cancer occurrence and death. Among sexually transmitted HPV types, those that frequently cause viral-induced cancers are classified as high-risk. The susceptibility of HPV to disinfection has not been described due to the lack of a suitable infectivity assay and the inability to produce sufficient HPV particles.   Introduction Source: Penn State Univ. BYU Susceptibility of Native and Synthetic HPV16 Virions to Clinical Disinfectants ASM Poster.
  • 7. Susceptibility of Native and Synthetic HPV 16 Virions to Clinical DisinfectantsJ.M. Meyers, E. Ryndock, M.J. Conway, K.L. O’Neill, C.M. Meyers, R.A. RobisonBrigham Young Univ. Provo, UT - Pennsylvania State College of Medicine Hershey, PA Abstract Method   All disinfectants were tested at recommended concentrations and at a 45 minute contact time. The results of these studies show that some disinfectants routinely used on medical instruments and devices may not be effective at inactivating HPV, leaving open the possibility of a nonsexual transmission route for HPV infection. Also, these data suggest that quasivirions may not have the same disinfectant resistance as more naturally-derived virions, suggesting that their use as surrogates may be problematic. Introduction Source: Penn State Univ. BYU Susceptibility of Native and Synthetic HPV16 Virions to Clinical Disinfectants ASM Poster.
  • 8. Susceptibility of Native and Synthetic HPV 16 Virions to Clinical DisinfectantsJ.M. Meyers, E. Ryndock, M.J. Conway, K.L. O’Neill, C.M. Meyers, R.A. RobisonBrigham Young Univ. Provo, UT - Pennsylvania State College of Medicine Hershey, PA Abstract Method   Epidemiological evidence suggests that infection routes exist outside of sexual transmission. Some of the non-sexual transmission of HPV can be ascribed to vertical transmission from infected mother to child, yet there remains a population who are positive for infection and have none of the classical risk factors. The purpose of this study was to establish an assay system for determining susceptibility of high-risk HPV16 using both virus propagation methods, and to determine the effect of various chemical disinfectants on these virions to establish the first disinfectant susceptibility data for HPV. Introduction Source: Penn State Univ. BYU Susceptibility of Native and Synthetic HPV16 Virions to Clinical Disinfectants ASM Poster.
  • 9. Susceptibility of Native and Synthetic HPV 16 Virions to Clinical DisinfectantsJ.M. Meyers, E. Ryndock, M.J. Conway, K.L. O’Neill, C.M. Meyers, R.A. RobisonBrigham Young Univ. Provo, UT - Pennsylvania State College of Medicine Hershey, PA Results Conclusions These results show the first disinfectant susceptibility data against infectious human papillomavirus particles. Specifically, we have shown the most common high-risk HPV type, HPV 16, to be resistant to many commonly used disinfectants. Both of the oxidative disinfectants we tested were shown to be effective, suggesting that this property might be important for activity against this virus. In general, ethanol has been shown to be more effective against envelope as compared to non-envelope viruses. However, ethanol has shown to be effective against polioviruses and adenoviruses. These data show ethanol to have no effective against HPV. To date, no viruses have shown significant resistance to glutaraldehyde. These data suggest that HPV 16 is resistant to both glutaraldehyde and ortho-phthalaldehyde. This is significant in that these are common high-level disinfectants used in clinics are when heat sterilization is not possible or available. Many of the ineffective disinfectants showed a consistent low increase in infectivity after treatment. Our data also supports a large amount of epidemiological and clinical data that suggest long-term environmental stability of HPV. While the vast majority of high-risk HPV infections can be attributed to sexual activity, this data helps explain non-vertical and non-sexual acquisition of HPV as well as a persistence of infection. Of the disinfectants tested, the only disinfectants able to achieve greater than a three log10 reduction of HPV infectivity were sodium hypochlorite (0.525% bleach solution by MarketLab) and a silver/PAA-based disinfectant (Steriplex by sBioMed). Preliminary data for the quasivirus with select disinfectants is also shown. All data were obtained using a 45 minute contact time. Table 1. Results of Disinfectant Testing LOG REDUCTION Native Virions 5.90 LOG REDUCTION Quasivirions 5.80 PEROXYACETIC ACID (1.3%) SILVER (0.03%) STERIPLEX ULTRA Source: Penn State Univ. BYU Susceptibility of Native and Synthetic HPV16 Virions to Clinical Disinfectants ASM Poster.
  • 10. Susceptibility of Native and Synthetic HPV 16 Virions to Clinical DisinfectantsJ.M. Meyers, E. Ryndock, M.J. Conway, K.L. O’Neill, C.M. Meyers, R.A. RobisonBrigham Young Univ. Provo, UT - Pennsylvania State College of Medicine Hershey, PA Results Conclusions These results show the first disinfectant susceptibility data against infectious human papillomavirus particles. Specifically, we have shown the most common high-risk HPV type, HPV 16, to be resistant to many commonly used disinfectants. Both of the oxidative disinfectants we tested were shown to be effective, suggesting that this property might be important for activity against this virus. In general, ethanol has been shown to be more effective against envelope as compared to non-envelope viruses. However, ethanol has shown to be effective against polioviruses and adenoviruses. These data show ethanol to have no effective against HPV. To date, no viruses have shown significant resistance to glutaraldehyde. These data suggest that HPV 16 is resistant to both glutaraldehyde and ortho-phthalaldehyde. This is significant in that these are common high-level disinfectants used in clinics are when heat sterilization is not possible or available. Many of the ineffective disinfectants showed a consistent low increase in infectivity after treatment. Our data also supports a large amount of epidemiological and clinical data that suggest long-term environmental stability of HPV. While the vast majority of high-risk HPV infections can be attributed to sexual activity, this data helps explain non-vertical and non-sexual acquisition of HPV as well as a persistence of infection. Of the disinfectants tested, the only disinfectants able to achieve greater than a three log10 reduction of HPV infectivity were sodium hypochlorite (0.525% bleach solution by MarketLab) and a silver/PAA-based disinfectant (Steriplex by sBioMed). Preliminary data for the quasivirus with select disinfectants is also shown. All data were obtained using a 45 minute contact time. Table 1. Results of Disinfectant Testing To date, no viruses have shown significant resistance to glutaraldehyde. These data suggest that HPV 16 is resistant to both glutaraldehyde and ortho-phthalaldehyde. This is significant in that these are common high-level disinfectants used in clinics when heat sterilization is not possible or available. While the vast majority of high-risk HPV infections can be attributed to sexual activity,this data helps explain non-vertical and non-sexual acquisition of HPV as well as a persistence of infection. Source: Penn State Univ. BYU Susceptibility of Native and Synthetic HPV16 Virions to Clinical Disinfectants ASM Poster.
  • 11. in cancer prevention …the facts Infection with high-risk “oncogenic” (tumor causing) types of human papillomavirus (HPV) is the cause of 100% of cervical cancers,90% of anal cancers, 40% of vulvar and vaginal cancers, at least 12% of oropharyngeal cancers, and 3% of oral cancers. Worldwide, HPV types 16 (HPV-16) and 18 (HPV-18) cause approximately 70% of cases of cervical cancer. “Infection by high-risk human papillomaviruses is causing as many as half a million cases of cervical cancer and more than 200,000 deaths among women per year, making it one of the most common forms of cancer. “Why is the virus causing cancer? The HPV infection is not cleared by the immune system and persists for decades. The virus release of E6 and E7 proteins then increases the risk of deterioration to cancer by causing cell proliferation and preventing programmed cell death," explains Dr. Per Jemth. Lung cancer is the most common malignancy worldwide. The results showed that HPV 16 and 18 DNA related sequences were found in 32% of lung cancer specimens. A genome-wide analysis revealed that a higher prevalence of HPV-positive lung tumors compared with HPV-negative tumors suggests that HPV-positive lung cancer could be related to HPV DNA integration. HPV DNA has been detected in aerosolized smoke and vapor during laser and electrocautery (wart removal) treatment of patients with cutaneous and genital warts and laryngeal (larynx) papillomatosis and also normal cells. Reports of possible transmission from patient to surgeon and surgical staff have been revealed. Textbook of pediatric infectious diseases, Volume 2 Fifth Edition Ralph D. Feigin
  • 12. in cancer prevention …the facts The American Cancer Society estimates there are about 34,000 cases of oropharyngeal (above the larynx) cancer each year. HPV is found in more than half of all throat cancers. Just as some types of HPV cause cervical cancer, increasingly the evidence is mounting that indicates types of the virus [especially HPV-16] play a large role in head and neck cancers, which include those of the oral cavity. American Social Health Assoc. Three out of four Americans between the ages of 15 and 49 have been infected with genital HPV in their lifetime. (75% “AMERICANS” not just Women) No data exist on the inactivation of HPV by alcohol or other disinfectants because in vitro replication of complete Virions has not been achieved because the HPV Virions cannot be grown in tissue culture. Journal of Occupational Health 100 ml (3.4 oz) of (Cidex)2.4% Glutaraldehyde was accidently spilled on a child's face during surgery. Fever, vomiting, excessively rapid heartbeat and breathing were noted for >6 hours after the accident. Chemical pneumonia was diagnosed. The child finally recovered from the life threatening event. About 6 million new genital HPV cases occur each year -- this is about 1/3 of all new STD infections.About 20 million -- men and women -- are thought to have an active HPV infection at any given time. Source: HPV and Cervical Cancer Prevention Resource Center (AHSA) www.ashastd.org . Journal of Occupational Health 2006; 48: 75-87 Effects of Glutaraldehyde Exposure on Human Health, Guideline for Disinfection and Sterilization in Healthcare Facilities, 2008HPV and Oral Diseases: An Interview with Robert Fleisher, DMD. CDC .

Hinweis der Redaktion

  1. The sBioMed® mission is to save lives and improve lives through groundbreaking infection control products that greatly improve quality of care. This mission combines continued research, committed partners and satisfied customers. The result of over 20 years of commitment and vision, STERIPLEX® technology provides the highest level of infection control available. Health care providers from around the world can now be armed with new tools in defending their patients from the world’s most dangerous microorganisms. Our teams of research scientists, medical professionals, educators and marketing experts will continually strive to improve patient care environments and to reduce incidence of health care acquired infections.